1. Amdisen A (1983) Serum level monitoring and clinical pharmacokinetics of lithium. In: Gibaldi M, Prescott L (eds) Handbook of clinical pharmacokinetics. Section IV. Therapeutic drug monitoring and dosage prediction. ADIS Health Science Press, New York Tokyo Mexico Sydney Auckland Hong Kong, pp 109–131.
2. Amdisen A, Nielsen-Kudsk (1986) Relationship between standardized twelve-hour serum lithium, mean serum lithium of the 24-hour day, dose regimen, and therapeutic interval. An evaluation based on pharmacokinetic simulations. Pharmacopsychiatry 19: 416–419.
3. American College of Clinical Pharmacology: Allen L, Kimura K, MacKichan J, Ritschel WA, Ad hoc committee for pharmacokinetic nomenclature (1982) In: Manual of symbols, equations & definitions in pharmacokinetics. Philadelphia. Am Coll Clin Pharmacol, pp 1-19.
4. Balant-Gorgia AE, Balant L (1987) Antipsychotic drugs. Clinical pharmacokinetics of potential candidates for plasma concentration monitoring. Clin Pharmacokinet 13: 65–90.
5. Baumann P, Tinguely D, Koeb L, Schöpf J, Le PK (1982) On the relationship between free plasma and saliva amitriptyline and nortriptyline. Int Pharmacopsychiatry 17: 136–146.